SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

TBN Tamboran Resources Corporation

Energy · Oil & Gas E&P · website · 45 employees
$0.24
52wk 0.17 – 0.34
Overall
62.0
Value
93.8
Growth
—
Health
100.0
Quality
0.0
Momentum
30.8
Dividend
—
Price
About Tamboran Resources Corporation

Tamboran Resources Corporation, a natural gas company, engages in developing unconventional gas resources in the Northern Territory of Australia. Its assets include a 25% non-operated working interest in EP 161; a 61.25% working interest in EPs 76, 98, and 117; and a 100% working interest in EPs 136 and 143, located in the Betaloo Basin. The company was founded in 2009 and is headquartered in Sydney, Australia.

Commodity exposure

Primary exposure: Crude Oil (Brent) (detected from the company profile: oil)

Crude Oil (Brent) primary
100.86 USD/bbl
1m: 5.5% · 1y: 57.3%
Natural Gas
2.92 USD/MMBtu
1m: -1.4% · 1y: -15.3%
Price analytics

Returns

1 day 4.3%
1 week -3.9%
1 month -14.0%
3 months 14.0%
6 months -20.7%
1 year 16.7%
3 years 78.9%

Risk

Volatility (1y ann.) 62.8%
Beta vs ASX 200 0.11
Sharpe (1y) 0.49
VaR 95% (1-day) -5.7%
Max drawdown (1y) -34.6%
Off 1-year high -25.5%

Technicals

RSI(14) 35
vs 50DMA -5.1%
vs 200DMA 3.6%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 93.8
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
84
Price / Sales
—
Growth —
Revenue growth (1y)
—
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 30.8
6-month return vs ASX 200
0
Price vs 200-day average
62
Price vs 50-day average
24
Position in 52-week range
44

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$1.71B
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
0.28
EV / EBITDA
-66.69
Price / Book
1.98
ROE
-4.5%
Operating margin
0.0%
Net margin
0.0%
Total cash
$219.14M
Total debt
$84.72M
Current ratio
2.61
Debt / Equity
0.09
Free cash flow
$-115.38M
Avg volume
3.74M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$0.00
  • Gross profit-$85.95K
  • Operating income-$32.99M
  • Net income-$36.90M
  • Diluted EPS-0.01
  • Free cash flow-$139.77M
  • Net debt-$13.04M
Sector peers (Energy)
TickerMkt cap P/EScore
WDS $59.39B 13.5 54.3
STO $27.74B 26.7 46.2
ALD $10.54B 7.3 51.3
NXG $8.60B — 39.5
YAL $7.54B 26.0 46.6
WHC $6.24B 15.8 50.1
VEA $5.36B 24.9 49.9
NHC $4.92B 30.7 53.6